Whitney Barham
Lab Manager
Last active: 10/28/2015

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker TP, Blackwell TS, Yull FE (2015) BMC Cancer : 647
    › Primary publication · 26424146 (PubMed) · PMC4590702 (PubMed Central)
  2. NF-κB-dependent airway inflammation triggers systemic insulin resistance. Cyphert TJ, Morris RT, House LM, Barnes TM, Otero YF, Barham WJ, Hunt RP, Zaynagetdinov R, Yull FE, Blackwell TS, McGuinness OP (2015) Am J Physiol Regul Integr Comp Physiol 309(9): R1144-52
    › Primary publication · 26377563 (PubMed) · PMC4666958 (PubMed Central)
  3. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. Wilson AJ, Saskowski J, Barham W, Yull F, Khabele D (2015) J Ovarian Res : 46
    › Primary publication · 26215403 (PubMed) · PMC4517540 (PubMed Central)
  4. Targeting the Wnt pathway in synovial sarcoma models. Barham W, Frump AL, Sherrill TP, Garcia CB, Saito-Diaz K, VanSaun MN, Fingleton B, Gleaves L, Orton D, Capecchi MR, Blackwell TS, Lee E, Yull F, Eid JE (2013) Cancer Discov 3(11): 1286-301
    › Primary publication · 23921231 (PubMed) · PMC3823757 (PubMed Central)
  5. Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles. Yu SS, Lau CM, Barham WJ, Onishko HM, Nelson CE, Li H, Smith CA, Yull FE, Duvall CL, Giorgio TD (2013) Mol Pharm 10(3): 975-87
    › Primary publication · 23331322 (PubMed) · PMC3595119 (PubMed Central)
  6. Intraductal injection of LPS as a mouse model of mastitis: signaling visualized via an NF-κB reporter transgenic. Barham W, Sherrill T, Connelly L, Blackwell TS, Yull FE (2012) J Vis Exp (67): e4030
    › Primary publication · 22971993 (PubMed) · PMC3490260 (PubMed Central)
  7. NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model. Connelly L, Barham W, Onishko HM, Chen L, Sherrill TP, Zabuawala T, Ostrowski MC, Blackwell TS, Yull FE (2011) Breast Cancer Res 13(4): R83
    › Primary publication · 21884585 (PubMed) · PMC3236346 (PubMed Central)
  8. NF-κB signaling in fetal lung macrophages disrupts airway morphogenesis. Blackwell TS, Hipps AN, Yamamoto Y, Han W, Barham WJ, Ostrowski MC, Yull FE, Prince LS (2011) J Immunol 187(5): 2740-7
    › Primary publication · 21775686 (PubMed) · PMC3159744 (PubMed Central)
  9. Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, Blackwell TS, Yull FE (2011) Oncogene 30(12): 1402-12
    › Primary publication · 21076466 (PubMed) · PMC3063854 (PubMed Central)
  10. Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. Connelly L, Barham W, Pigg R, Saint-Jean L, Sherrill T, Cheng DS, Chodosh LA, Blackwell TS, Yull FE (2010) J Cell Physiol 222(1): 73-81
    › Primary publication · 19746431 (PubMed) · PMC2783968 (PubMed Central)